Fig. 3: Risks and burdens of incident prespecified high-resolution post-acute COVID-19 outcomes.
From: High-dimensional characterization of post-acute sequelae of COVID-19
Risks and burdens were assessed at 6 months in mutually exclusive cohorts comprising non-hospitalized individuals with COVID-19, people who were hospitalized for COVID-19 and people who were admitted to intensive care for COVID-19 during the acute phase (first 30 days) of the infection. All VHA users served as the referent category. Outcomes were ascertained from day 30 after COVID-19 diagnosis until the end of follow-up. Adjusted hazard ratios and excess burdens are presented; error bars represent the 95% confidence interval. GERD, gastrointestinal reflux disease; ICU, intensive care unit.
